Peroxiredoxin 2 Is a Potential Objective Indicator for Severity and the Clinical Status of Subarachnoid Hemorrhage Patients.

Zheng Peng Cong Pang Xiao-Jian LiHua-Sheng ZhangJia-Tong ZhangQi ZhuHua-Jie XuYong-Yue GaoZong Zhuang Wei Li Qing-Rong Zhang Yue Lu Chun-Hua Hang

Published in: Disease markers (2023)

We found that the levels of Prx2 in the CSF and the ratio of Prx2 in the CSF and the blood within 3 days of onset can be used as a biomarker to detect the severity of the disease and the clinical status of the patient.

Keyphrases

subarachnoid hemorrhage
brain injury
end stage renal disease
chronic kidney disease
cerebral ischemia
newly diagnosed
ejection fraction
case report
patient reported outcomes
risk assessment
climate change
human health